Costo directo demestral por artritis reumatoidea en pacientes que concurren a un hospital universitario
Introduction: There are no medical puhlical.ions with economic analysis of rheumatoid arthritis patients (RA) from Argentina are lackirig. The objective of the present study is to determine the direct cost and its breakdown in patients with RA. Material and Methods: Fifty.- two patients who met the...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2022
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/36661 |
| Aporte de: |
| Sumario: | Introduction: There are no medical puhlical.ions with economic analysis of rheumatoid arthritis patients (RA) from Argentina are lackirig. The objective of the present study is to determine the direct cost and its breakdown in patients with RA. Material and Methods: Fifty.- two patients who met the American College of Rheumatology RA entena were included. Direct cost was calculated over a follow-up period of 6 months during year 2001. Variables were analyzed with Student's T test, Mann-Whitney U Test, cor ANOVA as corresponded. P values <0.05 were considered significant. Results: The mean monthly home income was $426.6 SD 272. The mean half-yearly direct costs was $677,5 SD 376.2. The components of the direct cost were identified and the mean for medication cost vas $606.7 (89%), for lab tests was $45,5 (7%), for medical attention $12,5 (2%) and other costs$2.4. No differences in total cost or in medication cost were found when compared considering age, evolution time of RA or HAQ scores. Conclusion: Haif- yearly direct cost in RA is excessively high considering the monthly mean income of the patients being analyzed. The cost of medication was the principal component of the direct cost.
|
|---|